OTCMKTS:MAYNF

Mayne Pharma Group Stock Forecast, Price & News

$0.34
+0.02 (+6.27 %)
(As of 04/9/2021 02:14 PM ET)
Add
Compare
Today's Range
$0.32
Now: $0.34
$0.34
50-Day Range
$0.21
MA: $0.27
$0.32
52-Week Range
$0.19
Now: $0.34
$0.35
Volume6,212 shs
Average Volume18,092 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, the United States, Korea, and internationally. The company operates through four segments: Generic Products, Specialty Brands, Metrics Contract Services, and Mayne Pharma International. It also offers oral drug delivery systems; and contract development and manufacturing services to third-party customers. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.

Industry, Sector and Symbol

Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:MAYNF
CUSIPN/A
CIKN/A
Phone61 8 8209 2666
Employees780
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

MarketRank

Overall MarketRank

0.48 out of 5 stars

Medical Sector

1620th out of 2,011 stocks

Drug Manufacturers - Major Industry

4th out of 4 stocks

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$0.34
+0.02 (+6.27 %)
(As of 04/9/2021 02:14 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MAYNF News and Ratings via Email

Sign-up to receive the latest news and ratings for MAYNF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Mayne Pharma Group (OTCMKTS:MAYNF) Frequently Asked Questions

What stocks does MarketBeat like better than Mayne Pharma Group?

Wall Street analysts have given Mayne Pharma Group a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Mayne Pharma Group wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Mayne Pharma Group?

Mayne Pharma Group saw a increase in short interest in March. As of March 15th, there was short interest totaling 16,500 shares, an increase of 75.5% from the February 28th total of 9,400 shares. Based on an average daily trading volume, of 10,600 shares, the short-interest ratio is currently 1.6 days.
View Mayne Pharma Group's Short Interest
.

How has Mayne Pharma Group's stock been impacted by COVID-19?

Mayne Pharma Group's stock was trading at $0.1962 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, MAYNF shares have increased by 72.8% and is now trading at $0.3390.
View which stocks have been most impacted by COVID-19
.

Who are Mayne Pharma Group's key executives?

Mayne Pharma Group's management team includes the following people:
  • Mr. Scott Anthony Richards, MD, CEO & Exec. Director (Age 57)
  • Mr. Peter Paltoglou, Chief Financial Officer
  • Mr. Stefan J. Cross, Pres of International Operations (Age 48)
  • Ms. Lisa Pendlebury, VP of Investor Relations & Communications
  • Ms. Kate Rintoul, Exec. VP & Gen. Counsel
  • Dr. Andrew O. Herdman Ph.D., VP of Group HR
  • Mr. Brant Schofield, Exec. VP of Specialty Brands Division (Age 55)
  • Mr. Daniel Moore, Exec. VP of Generics Products Division
  • Mr. Brenton Walter, Financial Controller
  • Mr. John S. Ross, Pres of Mayne Pharma USA

Who are some of Mayne Pharma Group's key competitors?

What is Mayne Pharma Group's stock symbol?

Mayne Pharma Group trades on the OTCMKTS under the ticker symbol "MAYNF."

How do I buy shares of Mayne Pharma Group?

Shares of MAYNF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Mayne Pharma Group's stock price today?

One share of MAYNF stock can currently be purchased for approximately $0.34.

How many employees does Mayne Pharma Group have?

Mayne Pharma Group employs 780 workers across the globe.

What is Mayne Pharma Group's official website?

The official website for Mayne Pharma Group is www.maynepharma.com.

How can I contact Mayne Pharma Group?

The company can be reached via phone at 61 8 8209 2666.


This page was last updated on 4/11/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.